News

This stock used to be a highflyer but has struggled in recent years as demand waned for its flagship product. Though Moderna ...
Last year over 100 people fell ill, with at least 14 having to be treated in hospital after being infected by two rare ...
The NHS has issued an alert to UK households over a 'highly contagious' illness, with two main symptoms which often persist ...
NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum antiviral drugs known as “nanoviricides”. These agents mimic cell surface ...